抑癌基因TIP30表达对大肠癌发生、发展的影响(3)
 |
| 第1页 |
参见附件。
[5] Smith RA，Cokkinides V，Brawley OW. Cancer screening in the United States， 2009： a review of current American Cancer Society guidelines and issues in cancer screening [J]. CA Cancer J Clin，2009，59(1)：27-41.
[6] 邵佳发，张树春，周媛媛，等.大肠癌相关肿瘤转移抑制基因的研究进展[J].医学综述，2009，15(22)：3424-3426.
[7] Siena S，Sartore-Bianchi A，Di Nicolantonio F，et al. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer [J]. J Natl Cancer Inst，2009，101(19)：1308-1324.
[8] Ei-Ommi K，Bird LE，Nichols CE，et a1. Crystal structure 0f CC3(TIP30)：implication for its role a tumor suppressor[J]. J Bid Chem，2005，280(18)：18229-18236.
[9] Ito M，Jiang C，Kristy-Krum MM，et al. TIP30 deficiency increases susceptibility to tumorigenesis [J]. Cancer Res，2003，63：8763-8767.
[10] Jiang C，Pecha J，Hoshino I，et al. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin [J]. Cancer Res，2007，67：3574-3582.
[11] Shi M，Yan SG，Xie ST，et al. Tip30-induced apoptosis requires translocation of Bax and involves mitochondrial release of cytochromec and Smac/DIABLO in hepatocellular carcinoma cells [J]. Biochim Biophys Acta，2008，1783(2)：263-274.
(收稿日期：2011-11-08 本文编辑：程 铭)
您现在查看是摘要介绍页，详见PDF附件(2682kb)。